Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026)
Tempest Therapeutics' (TPST) quarterly Prepaid Assets came in at $918000.0 in Q2 2026, up 11.54% year-over-year from $823000.0 in Q2 2025, and up 63.35% quarter-over-quarter from $562000.0 in Q4 2025.
Analysis
Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026) Analysis & Trends
Tempest Therapeutics has disclosed Prepaid Assets across 16 years of filings, most recently posting $918000.0 for Q2 2026.
- In Q2 2026, Prepaid Assets rose 11.54% year-over-year to $918000.0; the TTM figure through Jun 2026 stood at $918000.0 (up 11.54% YoY), while the FY2025 annual figure was $562000.0, down 53.4% from the prior year.
- Prepaid Assets came in at $918000.0 for Q2 2026 at Tempest Therapeutics, up from $562000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.3 million in Q3 2022 to a low of $424000.0 in Q2 2024.
- Average Prepaid Assets over 5 years is $1.2 million, with a median of $1.2 million recorded in 2024.
- The largest YoY upside for Prepaid Assets was 94.1% in 2025 against a maximum downside of 58.91% in 2025.
- Over 5 years, Prepaid Assets stood at $1.3 million in 2022, then fell by 10.79% to $1.1 million in 2023, then rose by 6.44% to $1.2 million in 2024, then slumped by 53.4% to $562000.0 in 2025, then soared by 63.35% to $918000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $918000.0 in Q2 2026, $562000.0 in Q4 2025, and $590000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 918,000.00 |
| Dec 31, 2025 | 562,000.00 |
| Sep 30, 2025 | 590,000.00 |
| Jun 30, 2025 | 823,000.00 |
| Mar 31, 2025 | 922,000.00 |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 931,000.00 |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.96 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 2.04 Mn |